首页> 外国专利> COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER

COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER

机译:用于治疗强迫症的组合物,装置和方法

摘要

In alternative embodiments, provided are pharmaceutical compositions and methods for treating, ameliorating, reversing and/or preventing (acting as a prophylaxis) an Obsessive-Compulsive Disorder (OCD), with or without an accompanying autism or an autism spectrum disorder (ASD), e.g., a regressive autism. In alternative embodiments, these pharmaceutical compositions and methods are dosaged and administered to children in need thereof. In alternative embodiments, pharmaceutical compositions and methods are dosaged, formulated and dosaged as solid, liquid or aerosol preparations or formulations. In alternative embodiments, pharmaceutical compositions comprise rifaximin as the sole antibiotic, or rixafimin and other antimicrobial or antibiotic agent, for example, vancomycin, metronidazole, tinidazole, secnidazole or a combination thereof. As there are various molecular forms of rifaximins, all these are useful and used in methods and compositions as provided herein
机译:在替代实施方案中,提供了用于治疗,改善,逆转和/或预防(充当预防)强迫症(OCD),伴有或不伴有自闭症或自闭症谱系障碍(ASD)的药物组合物和方法,例如,回归自闭症。在替代实施方案中,将这些药物组合物和方法配药并施用于需要其的儿童。在替代实施方案中,将药物组合物和方法配制成固体,液体或气雾剂或制剂,进行配制和配量。在替代实施方案中,药物组合物包含利福昔明作为唯一的抗生素,或利沙非明和其他抗微生物剂或抗生素剂,例如万古霉素,甲硝唑,替硝唑,塞尼达唑或其组合。由于存在利福昔明的多种分子形式,所有这些形式均有用并用于本文提供的方法和组合物中

著录项

  • 公开/公告号US2020179348A1

    专利类型

  • 公开/公告日2020-06-11

    原文格式PDF

  • 申请/专利权人 CENTRE FOR DIGESTIVE DISEASES;

    申请/专利号US201816471475

  • 发明设计人 THOMAS JULIUS BORODY;

    申请日2018-08-31

  • 分类号A61K31/437;A61K9;A61P25;A61K31/4164;A61K38/14;

  • 国家 US

  • 入库时间 2022-08-21 11:28:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号